Seeking value primarily in the non-US developed markets

The international value portfolio is constructed from an equity universe composed of companies with market capitalizations typically greater than $1 billion located throughout the non-US developed and emerging market countries. Through rigorous, bottom-up company analysis, we seek to identify undervalued stocks with upside potential. The investment process comprises three stages: quantitative screening and initial analysis, fundamental research and portfolio construction.

Benchmark
MSCI EAFE
Inception
June 11, 2001
Download Profile Sheet Download Flash Report Download Quarterly Review Risk Disclosures
Contact Us

Strategy overview

The portfolio managers discuss our International Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) -1.4%3.8%10.9%21.0%13.1%11.1%8.8%
Strategy (net) -1.4%3.5%10.5%20.5%12.6%10.7%8.4%
MSCI EAFE -0.7%10.0%14.0%20.3%9.2%9.7%6.7%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) -1.4%3.8%10.9%21.0%13.1%11.1%8.8%
Strategy (net) -1.4%3.5%10.5%20.5%12.6%10.7%8.4%
MSCI EAFE -0.7%10.0%14.0%20.3%9.2%9.7%6.7%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) -2.3%5.3%14.1%19.7%13.6%11.1%8.9%
Strategy (net) -2.4%5.0%13.7%19.3%13.2%10.7%8.5%
MSCI EAFE 0.9%10.8%16.2%19.0%9.9%9.6%6.7%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) -2.3%5.3%14.1%19.7%13.6%11.1%8.9%
Strategy (net) -2.4%5.0%13.7%19.3%13.2%10.7%8.5%
MSCI EAFE 0.9%10.8%16.2%19.0%9.9%9.6%6.7%
Fund 202520242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Strategy (gross) 40.2%5.9%29.0%-7.2%10.5%6.1%22.5%-18.0%28.6%1.1%-1.9%-4.6%27.6%24.6%-10.2%13.9%37.7%-43.0%9.8%27.5%9.0%29.5%48.4%-8.9%
Strategy (net) 39.7%5.5%28.5%-7.6%10.1%5.6%22.0%-18.4%28.0%0.7%-2.3%-5.0%27.1%24.1%-10.5%13.4%37.1%-43.2%9.4%27.0%8.5%29.0%47.8%-9.2%
MSCI EAFE 31.9%4.3%18.9%-14.0%11.8%8.3%22.7%-13.4%25.6%1.5%-0.4%-4.5%23.3%17.9%-11.7%8.2%32.5%-43.1%11.6%26.9%14.0%20.7%39.2%-15.7%
Table Header
Strategy (gross)
Strategy (net)
MSCI EAFE
202520242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
40.2%5.9%29.0%-7.2%10.5%6.1%22.5%-18.0%28.6%1.1%-1.9%-4.6%27.6%24.6%-10.2%13.9%37.7%-43.0%9.8%27.5%9.0%29.5%48.4%-8.9%
39.7%5.5%28.5%-7.6%10.1%5.6%22.0%-18.4%28.0%0.7%-2.3%-5.0%27.1%24.1%-10.5%13.4%37.1%-43.2%9.4%27.0%8.5%29.0%47.8%-9.2%
31.9%4.3%18.9%-14.0%11.8%8.3%22.7%-13.4%25.6%1.5%-0.4%-4.5%23.3%17.9%-11.7%8.2%32.5%-43.1%11.6%26.9%14.0%20.7%39.2%-15.7%

Portfolio (as of October 31, 2026)

Benchmark: MSCI EAFE
Asset Allocation
Table Header Strategy
Stocks 99.3%
Cash 0.7%
Strategy Characteristics
Table Header Strategy Benchmark
No. of holdings 67 654
Weighted avg. market cap (US $MM) $91,176 $109,249
FY2 price/earnings 11.7 14.0
Price/book value 1.8 2.3
Dividend yield (%) 2.5 2.7
TOP 10 HOLDINGS
Security Country Percent
ASTRAZENECA PLC United Kingdom 3.8%
KERING SA France 3.8%
RECKITT BENCKISER GROUP PLC United Kingdom 3.3%
RENESAS ELECTRONICS CORP Japan 3.0%
SIEMENS AG Germany 2.9%
ROLLS-ROYCE HOLDINGS PLC United Kingdom 2.9%
SAP SE Germany 2.9%
TENCENT HOLDINGS LTD China 2.9%
ALSTOM SA France 2.8%
CIE DE SAINT-GOBAIN SA France 2.7%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Strategy Benchmark
Industrials 20.1% 18.4%
Financials 19.4% 25.4%
Consumer Discretionary 12.1% 8.2%
Health Care 12.1% 11.3%
Information Technology 11.3% 10.2%
Consumer Staples 10.5% 7.1%
Communication Services 6.8% 3.8%
Materials 3.8% 5.8%
Utilities 3.2% 3.9%
Real Estate 0.0% 1.5%
Energy 0.0% 4.4%
TOP 10 COUNTRIES
Country Strategy Benchmark
United Kingdom 29.8% 14.8%
Germany 15.2% 8.8%
France 14.8% 9.3%
Japan 8.7% 24.0%
Netherlands 5.3% 5.5%
Sweden 3.3% 3.5%
Switzerland 3.3% 9.8%
United States 3.2% 0.0%
China 2.9% 0.0%
Italy 2.9% 3.1%
Regional Allocation
  • Euro 39.9%
  • Europe - Other 38.1%
  • Pacific 11.9%
  • North America 4.5%
  • Emerging Asia 4.4%
  • Emerging Europe, Middle East, Africa 0.6%

Commentary (As of October 31, 2026)

Highlights

  • Global equities declined in October, with emerging markets bearing the largest losses, as concerns about returns on AI investment weighed on stocks across multiple sectors.
  • Company-specific operational improvements remain the principal driver of our return expectations for the portfolio.
  • Inflation, large sovereign refinancing needs and rising debt-servicing costs could constrain the availability of private-sector capital, particularly for mid-sized companies, leveraged loan borrowers, and issuers rated below investment grade.

Portfolio Attribution

The Portfolio underperformed the Index during the month, due primarily to stock selection. Portfolio holdings in the consumer durables & apparel and media & entertainment industry groups, along with an underweight position in the energy industry group, detracted from relative performance. Holdings in the software & services industry group, as well as an overweight position in the health care equipment & services and food beverage & tobacco industry groups, offset some of the underperformance relative to the Index. The largest detractor was multinational luxury conglomerate, Kering SA (France). Additional notable detractors included semiconductor company, Renesas Electronics Corp. (Japan), and jet engine manufacturer, Rolls-Royce Holdings Plc (United Kingdom). The top contributor to return was pharmaceutical company, AstraZeneca PLC (United Kingdom). Other notable contributors included business software & services provider, SAP SE (Germany), and pharmaceuticals & biotechnology company, Roche Holding AG (Switzerland).

Investment Outlook

Company-specific operational improvements remain the principal driver of our return expectations for the portfolio. We favor businesses where management-led restructuring, stronger execution, and disciplined capital allocation can improve revenues, margins, and cash flow in ways we believe current valuations do not fully reflect. Lower crude prices and greater geopolitical stability should amplify these gains, but our investment cases rest primarily on actions companies can take to improve their earnings power.

Several spending and economic trends could provide additional support for portfolio holdings. Continued investment in AI should support revenues across a range of portfolio holdings, including the portfolio’s analog semiconductor manufacturers, electrical equipment providers, industrial suppliers, power generators, and electricity network operators. However, investment returns appear increasingly dependent on evidence that AI spending can generate sufficient returns. Improving purchasing managers’ indices in the US and Europe, increased defense spending, and accelerating industrial production in Japan should also support the portfolio’s cyclical holdings. Deep fundamental research remains essential to determining which companies can translate stronger demand into profitable growth and create upside from current valuations.

At the same time, inflation, large sovereign refinancing needs and rising debt-servicing costs could constrain the availability of private-sector capital, particularly for mid-sized companies, leveraged loan borrowers, and issuers rated below investment grade. These pressures warrant careful stock selection, especially in financials, where funding conditions and borrowers’ financial health can materially affect earnings. Many financial sector stocks currently trade at historically high valuations. We scrutinize balance sheets, cash flow, and credit exposures as part of our assessment of potential returns and downside risk. Across the portfolio, our focus remains on identifying undervalued companies with credible paths to earnings improvement, supported by detailed company research and valuation discipline.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Past performance does not guarantee future results. For a description of our performance attribution methodology, or to obtain a list showing every holding's contribution to the overall account's performance during the quarter, please contact our product manager, Kevin Moutes, at 310-231-6116 or [email protected].